The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

Every day I catch myself turning to tell my husband something, little things about the grandchildren or something I’ve seen ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

Low testosterone may increase the risk of aggressive prostate cancer progression during active surveillance. Learn more about the findings.

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

Detailed results from pivotal TALAPRO-3 study presented at ASCO 2026 and published in The New England Journal of Medicine TALZENNA plus XTANDI demonstrated a 52% reduction in the risk of radiographic ...

More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep PSA ...